Periodontitis is a chronic inflammatory and bone-destructive disease. Development of periodontitis is associated with dysbiosis of the microbial community, which may be caused by periodontal bacteria, such as Porphyromonas gingivalis. Mast cells are sentinels at mucosal surfaces and are a potent source of inflammatory mediators, including tumor necrosis factors (TNF), although their role in the pathogenesis of periodontitis remains to be elucidated. This study sought to determine the contribution of mast cells to local bone destruction following oral infection with P. gingivalis. Mast cell-deficient mice (Kit W-sh/W-sh ) were protected from P. gingivalis-induced alveolar bone loss, with a reduction in anti-P. gingivalis serum antibody titers compared with wild-type infected controls. Furthermore, mast cell-deficient mice had reduced expression of Tnf, Il6, and Il1b mRNA in gingival tissues compared with wild-type mice. Mast cell-engrafted Kit W-sh/W-sh mice infected with P. gingivalis demonstrated alveolar bone loss and serum anti-P. gingivalis antibody titers equivalent to wild-type infected mice. The expression of Tnf mRNA in gingival tissues of Kit W-sh/W-sh mice was elevated following the engraftment of mast cells, indicating that mast cells contributed to the Tnf transcript in gingival tissues. In vitro, mast cells degranulated and released significant TNF in response to oral bacteria, and neutralizing TNF in vivo abrogated alveolar bone loss following P. gingivalis infection. These data indicate that mast cells and TNF contribute to the immunopathogenesis of periodontitis and may offer therapeutic targets.
Introduction
Periodontitis is a chronic inflammatory disease that destroys the alveolar bone and connective tissues supporting the teeth. Periodontitis is one of the most prevalent chronic infectious conditions of humans and is the leading cause of tooth loss among adults (Kassebaum et al. 2014) . The "keystone" pathogen, Porphyromonas gingivalis, can trigger the microbial dysbiosis characteristic of periodontitis (Hajishengallis et al. 2011) ; in parallel, the responding cells and cytokine milieu are central to the tissue destruction (Cekici et al. 2014; Hajishengallis 2014) .
Mast cells are sentinels at mucosal surfaces and, as such, have a pivotal role in orchestrating both innate and adaptive immune responses against local microbial challenge (Gordon and Galli 1990) . In vivo studies have demonstrated that mast cells can bind to, phagocytose, and kill enterobacteria (Malaviya et al. 1994) and present bacterial antigens to T cells (Malaviya, Twesten, et al. 1996) . Mast cells contain a vast array of mediators in their granules, including large amounts of tumor necrosis factors (TNF). In a model of acute septic peritonitis, TNF blockade suppressed the protective role of mast cells via reduced neutrophil influx (Echtenacher et al. 1996; Malaviya, Ikeda, et al. 1996) .
Mast cells are integral to anaphylaxis and other allergic disorders but are also implicated in chronic inflammatory diseases, such as rheumatoid arthritis (Lee et al. 2002) . Within inflamed periodontal tissues, the proportion of degranulated cells in the tissues is associated with the severity of periodontitis. However, whether mast cells migrate into inflamed tissue or simply alter their activation state remains unknown. Some studies report increases in mast cell numbers in periodontitis, while others report no difference; some suggest the distribution of mast cells in the inflamed tissue changes (Huang et al. 2013; Lagdive et al. 2013; Huang et al. 2014) .
Oral mucosal mast cells contain TNF in their granules. In inflammation, Tnf mRNA upregulation, in parallel with mast cell degranulation and depletion of intracellular TNF, is consistent with continued TNF synthesis and release by mast cells (Walsh et al. 1995) . Thus, mast cells may contribute to protection from potentially invasive bacteria and to the local and systemic pathologic inflammation associated with periodontitis.
We hypothesized that mast cells, with their armamentarium of inflammatory mediators, could contribute to the local and systemic pathology associated with periodontitis. We sought to determine the contribution of mast cells and TNF to local bone destruction following oral infection with P. gingivalis.
Materials and Methods

Multispecies Oral Biofilm Model
Overnight cultures of Streptococcus mitis NCTC 12261, Streptococcus intermedius NCTC 11324, Streptococcus oralis NCTC 11427, Aggregatibacter actinomycetemcomitans ATCC 43718, Veillonella dispar NCTC 11831, Actinomyces naeslundii ATCC 19039, Fusobacterium nucleatum ATCC 10953, F. nucleatum subspecies vincentii ATCC 49256, P. gingivalis W83, and Prevotella intermedia ATCC 25611 were standardized in artificial saliva and added sequentially to Thermanox coverslips as previously described to generate a multispecies oral biofilm (Millhouse et al. 2014 ).
Bone Marrow-derived Mast Cell Culture
Bone marrow was obtained from C57BL/6 mice and bone marrowderived mast cells (BMMCs) generated as previously described (Kuehn et al. 2010) . After 4 wk, BMMCs were assessed by flow cytometry to determine purity and maturity. Cell suspensions were resuspended in Fc block (CD16/32; eBioscience, San Diego, CA, USA) containing fluorochrome-labeled antibodies against FcεR1 and CD117 or similarly labeled isotype controls. Cells were analyzed with a FACscalibur (BD Biosciences, San Jose, CA, USA) and data analyzed with Flowjo (Tree Star Inc., Ashland, OR, USA). Cell viability, assessed by exclusion of 7-aminoactinomycin, was >98%. All cultured cells were CD117 positive, and >90% were double positive for CD117 and FcεR1.
For coculture experiments, mature BMMCs were seeded in 24-well plates at 5 × 10 5 cells per well of Dulbecco's Modified Eagle's Medium. BMMCs were cultured adjacent to the biofilm-covered coverslip attached to a hanging cell culture insert as previously described (Millhouse et al. 2014) for 2 h at 37 °C in 5% CO 2 .
Mast Cell Degranulation
β-hexosaminidase activity of cell culture supernatants and cell lysates was assessed as a proxy for mast cell degranulation via a previously described method (Kuehn et al. 2010) . The percentage degranulation for each condition was calculated as follows: 100 × (total supernatant content) / (supernatant + lysate).
ELISA
The concentrations of TNF and IL-6 in the BMMC supernatants following coculture and mast cell protease 1 in mouse serum were measured by enzyme-linked immunosorbent assay (ELISA) with paired antibodies (eBioscience) according to the manufacturer's instructions.
Murine Model of Periodontal Disease
Female BALB/c mice (Harlan, Loughborough, UK), female and male C57BL/6 mice (bred in-house at Strathclyde University), or age-and sex-matched mast cell-deficient C57BL/6 Kit W-sh / W-sh mice (originally sourced from Jackson Laboratory, Bar Harbor, ME, USA, and subsequently bred inhouse at the University of Strathclyde; Grimbaldeston et al. 2005) were maintained before and during experiments in specific-pathogen-free conditions with ad libitum food and water at the universities of Strathclyde and Glasgow. All work was performed in accordance with UK Home Office regulations and after ethical approval from local research ethics committees and is reported according to the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. Mice were orally infected with 10 9 colony-forming units of P. gingivalis W83 (ATCC, Middlesex, UK) in 2% carboxymethylcellulose on 4 consecutive days as previously described (Baker et al. 1994 ). Sham-infected control mice received carboxymethylcellulose alone. At 6 wk postinfection (PI), serum, gingival tissues, and maxillae were collected under terminal general anesthesia. In other experiments, mice received 0.1 mg/mouse of anti-TNF antibody or isotype control antibody (both BioLegend), administered intraperitoneally on days -3, 0, 7, and 14 PI. Kit W-sh/W-sh mice received 5 × 10 5 mature BMMCs/mouse, administered intravenously on days -28 and 0, as outlined in the figure legends. The mast cell reconstitution was carried out according to previous studies. Following transfer, it takes 4 wk to establish mast cells in the tissues, which remain readily detectable 12 wk after transfer (Grimbaldeston et al. 2005 ).
Assessment of Alveolar Bone Loss
The maxillae were separated from the skull and gingivae removed. Maxillae were defleshed and treated as previously described (Baker et al. 1994) . Images were captured with an Olympus SZX7 stereo zoom microscope fitted with an SC100 digital color camera. Measurements of the distance between the cementoenamel junction and the alveolar bone crest were made with ImageJ software (National Institutes of Health, Bethesda, MD, USA) to assess alveolar bone loss as previously described (Baker et al. 1994 ).
Anti-P. gingivalis ELISAs
Antibody titers to P. gingivalis in the serum samples were measured as previously described (Malcolm et al. 2015) .
TaqMan Real-time Polymerase Chain Reaction
RNA was extracted from periodontal tissues with the RNeasy Fibrous Tissue Kit (Qiagen, Hilden, Germany), reverse transcribed with High Capacity RNA-to-cDNA (Applied Biosystems, Life Technologies, Carlsbad, CA, USA), with mRNA expression then analyzed by TaqMan real-time polymerase chain reaction, with murine primers and fluorescent probe assays obtained from Applied Biosystems (Il6: Mm00446190_m1, Il1b: Mm00 434228_m1, Tnf: Mm 0044 3258_m1, Il17: Mm00439618_m1, Mpo: Mm01 298424_m1, Tpsab1: Mm00491950_m1, Mcpt4: Mm00487636_g1). Analysis was performed in duplicate, with gene expression normalized to 18S and with relative expression of the gene of interest calculated by 2−ΔCT. The data are presented as the fold change in expression of the gene of interest in the test population-for example, P. gingivalis-infected test group normalized to the control (sham-infected) population.
Statistical Analyses
Data were analyzed by Student's t test or analysis of variance with Tukey comparison, as indicated in the figure legends, with GraphPad Prism 6 (La Jolla, CA, USA).
Results
Mast Cell-deficient Mice Are Protected from P.
Gingivalis-mediated Alveolar Bone Loss
To elucidate the role of mast cells in P. gingivalis-induced inflammatory bone loss, wild-type (WT) or mast cell-deficient mice (Kit W-sh / W-sh ) were orally infected with P. gingivalis (experiment outline Fig. 1A ). In WT animals, alveolar bone loss was significantly greater following P. gingivalis infection when compared with sham-infected controls (P < 0.001). In contrast, P. gingivalis infection failed to elicit alveolar bone loss in Kit W-sh / W-sh mice ( Fig. 1B [P < 0.05 compared with P. gingivalis-infected WT]). Infection of WT mice with P. gingivalis induced a robust serum IgG anti-P. gingivalis antibody response (Fig. 1Ci ), which appeared dominated by IgG1. Anti-P. gingivalis IgG1 titers were significantly reduced in infected Kit W-sh / W-sh as compared with infected WT mice (P < 0.05, Fig. 1Cii ). There was no statistically significant difference in the total IgG in the serum of infected Kit W-sh / W-sh compared with infected WT mice.
In the absence of infection, there was greater expression of Tnf and Il1b in the gingival tissues of WT mice compared with Kit W-sh/W-sh . P. gingivalis infection of WT mice resulted in increased expression of Il6, Tnf, and Il1b mRNA when compared with WT sham-infected controls ( Fig. 1D) ; the difference was statistically significant for Il6 only (Fig. 1Dii ). After infection with P. gingivalis, expression of Il6 and Tnf in the gingival tissues of Kit W-sh/W-sh mice remained significantly reduced as compared with P. gingivalis-infected WT mice (P < 0.05). Overall, there appeared to be a reduction in the expression of Tnf, Il1b, and Il6 in the gingival tissues from Kit W-sh/W-sh mice as compared with normal WT mice, which suggests that mast cells may be a significant source of the cytokine transcripts in gingival tissues in both health and disease. Expression of Il17 was evaluated in the gingival tissues, and no significant differences were found in any of the groups (data not shown).
BMMC Engraftment Restores Alveolar Bone Loss in P. gingivalis-infected Kit-W Mice
The Kit W-sh / W-sh mice have compromised kit signaling. Kit (stem cell ligand) is essential for mast cell development but is also expressed on all hematopoietic stem cells. As a result, kit mutant mice have a number of immune alterations (Grimbaldeston et al. 2005) . Although these are relatively mild in the Kit W-sh / W-sh mice versus other kit mutants, we sought to investigate whether the reduced alveolar bone loss observed in the Kit W-sh / W-sh was mediated by mast cells and no other phenotypic abnormality of Kit W-sh/W-sh mice. Mast cells were engrafted to reconstitute Kit W-sh/W-sh mice with BMMCs prior to infection with P. gingivalis as outlined ( Fig. 2A) . Engrafted BMMCs were >90% double positive for CD117 (c-kit) and FcεR1 (Fig. 2B) . As indicators of mast cell engraftment, serum mast cell protease 1 (MCPT1) was assessed, which was readily detectable in WT mice and undetectable in the serum of Kit W-sh/W-sh mice but could be detected, albeit at a low level, in the serum of Kit W-sh/W-sh mice engrafted with BMMCs, indicating some mast cell engraftment in Kit W-sh/W-sh mice at 6 wk post-BMMC transfer (Fig. 2C ). Next, we sought to determine whether mast cells were engrafted within the gingival tissues of Kit W-sh/W-sh mice following BMMC transfer. Mast cell tryptase 1 (TPSAB1) and mast cell protease 4 (MCPT4) were expressed in WT mice but were either undetectable (TPSAB1) or at the limit of detection (MCPT4) in Kit W-sh/W-sh mice (Fig. 2Di and ii) . In BMMC-engrafted Kit W-sh/W-sh mice, both TPSAB1 and MCPT4 mRNA transcripts were detected in the gingival tissues indicating that mast cells had engrafted to the gingival tissues in these mice. Kit W-sh/W-sh mice demonstrate neutrophilia (Grimbaldeston et al. 2005) , and therefore we quantified the level of myeloperoxidase (MPO) expression in gingival tissues as a surrogate measure of neutrophil infiltration. MPO mRNA was significantly elevated in the gingival tissues of Kit W-sh/W-sh infected mice as compared with infected BMMC-engrafted Kit W-sh/ W-sh mice (Fig. 2Diii ). There was no difference in the level of MPO mRNA in the gingival tissues of BMMC transferred Kit W-sh/W-sh mice compared with WT mice.
We next sought to investigate the alveolar bone loss in BMMC-engrafted Kit W-sh/W-sh mice. As before, P. gingivalis infection of WT mice induced alveolar bone loss, and this phenotype was attenuated in Kit W-sh/W-sh -infected mice (P < 0.05 [ Fig. 2E] ). The disease phenotype was recapitulated in BMMC-engrafted, P. gingivalis-infected Kit W-sh/W-sh mice, with similar alveolar bone loss to that observed in WT-infected mice (P < 0.01 [ Fig. 2E]) . Similarly, the predominantly IgG1 serum antibody response to P. gingivalis was restored following BMMC engraftment of Kit W-sh / W-sh -infected mice (Fig. 2F) .
The expression of Tnf mRNA was greater in the gingival tissues of infected Kit W-sh / W-sh mice following BMMC engraftment as compared with infected Kit W-sh / W-sh that had not received mast cells (P < 0.05 [ Fig. 2G]) . These data indicate that mast cells are a significant source of Tnf transcript in gingival tissues. We next examined the ability of BMMCs to produce and release TNF protein in response to oral bacteria. 
Mast Cells Release TNF and IL-6 in Response to Oral Bacteria
In vitro exposure of BMMC to a periodontitis-associated biofilm model induced significant mast cell degranulation (P < 0.05 compared with media control [Fig. 3A] ) and significant TNF and IL-6 release (P < 0.001 compared with media control [Fig. 3B, C] ), demonstrating that mast cells can be stimulated to release TNF in response to oral bacteria. Given that mast cells appear to be a significant source of the Tnf transcript in vivo, we hypothesized that TNF release from mast cells may contribute to alveolar bone loss in the murine model of periodontitis. The role of TNF in periodontitis has long been recognized (Kinane et al. 2011 ) and TNF blockade described in primates (Graves et al. 1998) . We next sought to evaluate TNF blockade in this murine model of P. gingivalis-induced alveolar bone loss.
TNF Blockade Reduces the Severity of P. gingivalis-induced Alveolar Bone Loss
Anti-TNF or isotype control antibodies were administered to BALB/c mice orally infected with P. gingivalis (Fig. 4A) . P. gingivalis-infected isotype control-treated mice demonstrated significant alveolar bone loss when compared with sham-infected controls (P < 0.001 [ Fig. 4B] ). Anti-TNF treatment significantly reduced the severity of alveolar bone loss in P. gingivalis-infected animals versus infected isotype-control mice (P < 0.05). However, this anti-TNF treatment regime failed to completely attenuate alveolar bone loss, which remained significantly greater than that of the sham-infected mice (P < 0.05). A robust serum IgG anti-P. gingivalis antibody response was induced following infection with P. gingivalis (Fig. 4C) , which was reduced in mice treated with anti-TNF antibody.
Discussion
These data show that mast cell deficiency is associated with protection against the local tissue destruction of periodontitis. Mast cell-deficient mice were completely protected from P. gingivalis-induced periodontitis, and mast cells contributed to the expression of Tnf in gingival tissues.
To our knowledge, this is the first study to use a mast celldeficient mouse to investigate the role of mast cells in periodontitis. Previous studies demonstrated changes in mast cell numbers and degranulation with immunohistochemistry (Gemmell et al. 2004; Huang et al. 2013; Huang et al. 2014 ). Treatment of beagle dogs with lodoxamide ethyl, an inhibitor of mast cell degranulation, reduced the level of alveolar bone loss as compared with untreated controls over a 1-y period (Jeffcoat et al. 1985) , suggesting that therapeutic targeting of mast cells may ameliorate periodontal disease. Our data provide evidence that mast cells and their products are directly involved in periodontal destruction, further confirmed by engrafting cultured mast cells into Kit W-sh / W-sh mice and restoring the disease phenotype.
Oral administration of P. gingivalis induced a robust serum anti-P. gingivalis antibody response in WT mice, dominated by Ig1 and characteristic of a Th2-mediated response (Spellberg and Edwards 2001) . Th2 immunity is generally associated with mast cell degranulation, and mast cells have been shown to support B cell antibody class switching (recently reviewed by Bulfone-Paus and Bahri 2015). Kit W-sh / W-sh mice show compromised IgG responses following challenge with mucosal adjuvants (Fang et al. 2010) . Thus, while the reduced anti-P. gingivalis antibody responses in Kit W-sh / W-sh -infected mice may indicate a failure of bacterial colonization and invasion, data from other studies suggest an important role of mast cells in driving humoral immunity.
Rheumatoid arthritis shares similar immunopathogenesis with periodontitis (Farquharson et al. 2012) . In vivo studies of mast cells in arthritis have revealed intriguing inconsistencies dependent on the nature of the mast cell deficiency and subtleties of the model of disease. Mast cells are redundant for the development of serum-induced arthritis in Kit W-sh / W-sh mice (Zhou et al. 2007) . This was confirmed with Cpa3 Cre mice, which are mast cell deficient and have a reduction in the number of basophils but are otherwise immunologically normal (Scholten et al. 2008) . In other studies, mast cells were redundant in the collagen-induced arthritis model in Kit W-sh / W-sh mice (Pitman et al. 2011 ), but Mcpt5 Cre -iDTR mice (a kit-independent model) were protected from collagen-induced arthritis (Schubert et al. 2014) . These data highlight the complexities of different models of disease and different models of mast cell deficiency. It would therefore be useful to explore the murine model of periodontitis in a mast celldeficient model that does not rely on impaired kit signaling.
Although multiple cells implicated in periodontitis can release TNF in response to bacterial stimulation, mast cells contain particularly abundant preformed TNF (Gordon and Galli 1990) . Our observation of reduced Tnf in mast celldeficient tissues supports the hypothesis that mast cells in periodontal tissues contribute to elevated TNF. In periodontitis, TNF can play a tissue destructive rather than antibacterial protective role: in a rat ligature model, administration of human recombinant TNF exacerbated the inflammatory cell infiltrate and alveolar bone resorption (Gaspersic et al. 2003) . Local administration of neutralizing anti-TNF antibodies reduced alveolar bone loss in a primate model of periodontitis (Graves et al. 1998). Similarly, p55TNFR-1-KO mice demonstrated less severe bone loss and reduced inflammation in periodontitis induced by Aggregatibacter actinomycetemcomitans, although the bone loss was not fully ameliorated (Garlet et al. 2007 ). In the present study, we observed a significant reduction in the serum antibody response to P. gingivalis following anti-TNF treatment, possibly due to loss of TNF induction of cell migration, as reported in p55TNFR-1-KO mice. Alveolar bone loss was completely abrogated in P. gingivalis-infected, mast cell-deficient Kit W-sh / W-sh mice, but neutralizing TNF, as in other studies (Garlet et al. 2007) , only partially prevented the bone loss. Accurately defining the contribution of mast cell-derived TNF could be achieved by reconstitution of Kit W-sh / W-sh mice with TNF knockout mast cells. TNF has often been considered a master regulator within the cytokine network. TNF also synergizes with other cytokines, such as IL-17, amplifying its impact on inflammation (Griffin et al. 2012) .
In rheumatoid arthritis, mast cell expression of IL-17 has been documented (Hueber et al. 2010) . IL-17 drives neutrophil recruitment to the inflamed periodontium (Yu et al. 2007; Eskan et al. 2012) . Surprisingly, there were no consistent changes in Il17 expression in the gingival tissues, irrespective of the presence of mast cells or infection.
In addition to TNF, mast cells contain an array of proinflammatory cytokines in their granules, including IL-1β and IL-6 (Steinsvoll et al. 2004) , both of which are elevated in periodontitis (Graves et al. 1998; Reis et al. 2014 ). In the present study, there was marked release of both TNF and IL-6 from mast cells in vitro following stimulation with periodontal bacteria. Moreover, there was reduced expression of cytokine transcripts in the gingival tissues of healthy Kit W-sh / W-sh mice compared with WT mice, indicating that mast cells may constitutively generate some cytokines as previously documented (Okayama et al. 1995) or respond to the commensal flora with a baseline elevation of cytokine profile.
Recently, mast cell-derived CXCL1 has been implicated in neutrophil recruitment to sites of inflammation (Wezel et al. 2015) . In addition to cytokines and chemokines, mast cells exert their effects via serine proteases released from mast cell granules. In humans, mast cell tryptase expression correlated with the degree of inflammatory infiltrate and the severity of periodontal disease (Huang et al. 2013) . These serine proteases are important for the recruitment of neutrophils to sites of infection (Huang et al. 1998; Tani et al. 2000) . This is particularly pertinent to periodontal diseases in which hypo-and hyperrecruitment of neutrophils is associated with bone loss (Hajishengallis 2014) . Delineating the hierarchy of the neutrophil and mast cell responses is complex, particularly as mice with mutations in CD117, such as the Kit-W, show a tendency to neutrophilia (Grimbaldeston et al. 2005 ) and would therefore be more accurately investigated in models of inducible mast cell deficiency, such as the Mcpt5 Cre -iDTR mice (Schubert et al. 2014) .
Our results provide evidence to indicate that mast cells are a key cell type in the immunopathogenesis of PD and that these cells contribute to the expression of TNF, a key mediator in PD. These new data provide further basis for exploring strategies aimed at preventing and treating PD. Targeting mast cells and TNF is of particular interest given the breadth of existing therapies, which are already in clinical use for treating a range of allergic and inflammatory conditions, respectively. (C) Serum anti-P. gingivalis antibody was assessed by ELISA at the end of the experiment: (i) total IgG, (ii) IgG1 isotype, and (iii) IgG2c isotype. Data shown are mean ± SD (n = 5 mice/group). *P < 0.05, **P < 0.01, ***P < 0.001, by analysis of variance with Tukey comparison.
